ACM
QTTB icon

ADAR1 Capital Management’s Q32 Bio QTTB Stock Holding History

ADAR1 Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,000
Closed -$225K – 350
2026
Q1 		$225K Buy
35,000
+15,000
+75% +$71.3K 0.01% 256
2025
Q4 		$66.4K Buy
+20,000
New +$56.5K ﹤0.01% 262
2024
Q4 		– Sell
-64,245
Closed -$2.87M – 310
2024
Q3 		$2.87M Sell
64,245
-92,259
-59% -$3.39M 0.47% 41
2024
Q2 		$2.81M Sell
156,504
-31,063
-17% -$743K 0.53% 30
2024
Q1 		$3.2M Buy
187,567
+171,252
+1,050% +$2.36M 0.73% 26
2023
Q4 		$179K Buy
+16,315
New +$239K 0.06% 84

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ADAR1 Capital Management's QTTB Position: Q2 2026 in Review

ADAR1 Capital Management sold out of Q32 Bio (QTTB) in Q2 2026, closing a stake of 35,000 shares — an estimated $225K sold.

ADAR1 Capital Management first reported a position in QTTB in Q4 2023 and held it in 6 quarters. The position peaked at $3.2M in Q1 2024. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • ADAR1 Capital Management reported no remaining Q32 Bio position as of Q2 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 35,000 Q32 Bio shares in Q2 2026, an estimated $225K.
  • ADAR1 Capital Management first reported a position in Q32 Bio in Q4 2023 and held it in 6 quarters.
  • ADAR1 Capital Management's Q32 Bio position peaked at $3.2M in Q1 2024.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.